The latest updated of drug registration lists on 07 July 2025.

Close

No Brand Name Ingredients Dosage Form Primary Packaging Indications EDL License Owner Manufacturer Country Activity Reg No. Reg Date Expiry Date Action
2731 IMATINIB DENK 100 MG IMATINIB MESILATE 119.20 MG EQ.TO IMATINIB BASE 100 MG FILM COATED TABLET PVC/PE/PVDC-ALU BLISTERPACK FOR THE TREATMENT OF ADULT AND PAEDIATRIC PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKAEMIA FOR WHOM BONE MARROW TRANSPLANTATION IS NOT CONSIDERED AS THE FIRST LINE OF TREATMENT NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD HAUPT PHARMA AMAREG GMBH GERMANY CERTIFICATE RELEASED 04 I 5912/25 07-APR-2025 06-APR-2030 View
2732 IMATINIB DENK 400 MG IMATINIB MESILATE 478 MG EQ.TO IMATINIB BASE 400 MG FILM COATED TABLET PVC/PE/PVDC-ALU BLISTERPACK FOR THE TREATMENT OF ADULT AND PAEDIATRIC PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKAEMIA FOR WHOM BONE MARROW TRANSPLANTATION IS NOT CONSIDERED AS THE FIRST LINE OF TREATMENT NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD HAUPT PHARMA AMAREG GMBH GERMANY CERTIFICATE RELEASED 04 I 5913/25 07-APR-2025 06-APR-2030 View
2733 INF-OPH EYE DROPS PREDNISOLONE ACETATE 1% W/V SUSPENSION BOTTLE ACUTE OR CHRONIC NON INFECTED CONJUNCTIVITIS, ALLERGIC INFLAMMATORY PROCESSES OF THE EYELID, CORNEA AND ANTERIOR SEGMENT OF THE GLOBE EG., ALLERGIC CONJUCTIVITIS, IRITIS, IRIDOCYCLITIS, CHOROIDITIS,OPTIC NEURITIS, SYMPATHETIC OPTHALMIA, CORNEAL INJURY, SCAR-PREVENTION IN EYE SURGERY AND EYE INJURY NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD SENG THAI COMPANY CO.,LTD THAILAND CERTIFICATE RELEASED 10 I 5618/23 09-Oct-2023 08-Oct-2026 View
2734 INSULATARD HUMAN INSULIN (RDNA) 100IU/ML SUSPENSION FOR INJECTION Vial TREATMENT OF DIABETES MELLITUS NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD NOVO NORDISK A/S DENMARK CERTIFICATE RELEASED 01 I 2878/07 03-Oct-2023 02-Oct-2026 View
2735 INSULATARD HUMAN INSULIN (RDNA) 100IU/ML SUSPENSION FOR INJECTION Vial TREATMENT OF DIABETES MELLITUS NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD NOVO NORDISK PRODUCTION SAS FRANCE CERTIFICATE RELEASED 07 I 4983/20 03-Oct-2023 02-Oct-2026 View
2736 INSULATARD PENFILL HUMAN INSULIN (RDNA) 100 IU/ML SUSPENSION FOR INJECTION cartridge TREATMENT OF DIABETES MELLITUS NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD NOVO NORDISK A/S DENMARK CERTIFICATE RELEASED 01 I 2847/07 02-NOV-2023 01-NOV-2026 View
2737 LEVEMIR FLEXPEN INSULIN DETEMIR 100 U/ML SOLUTION FOR INJECTION PRE-FILLED PEN TREATMENT OF DIABETES MELLITUS IN ADULTS, ADOLESCENTS AND CHILDREN AGED 2 YEARS NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD NOVO NORDISK A/S DENMARK CERTIFICATE RELEASED 06 I 4507/18 16-DEC-2024 15-DEC-2029 View
2738 LEVEMIR FLEXPEN INSULIN DETEMIR 100 U/ML SOLUTION FOR INJECTION PRE-FILLED PEN TREATMENT OF DIABETES MELLITUS IN ADULTS, ADOLESCENTS AND CHILDREN AGED 2 YEARS AND ABOVE NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD NOVO NORDISK PRODUCTION SAS FRANCE CERTIFICATE RELEASED 05 I 5097/21 08-APR-2024 07-APR-2027 View
2739 LEVO-DENK 500 LEVOFLOXACIN HEMIHYDRATE 512.46 MG EQ. TO LEVOFLOXACIN 500 MG FILM COATED TABLET ALU-ALU BLISTER IS INDICATED IN ADULTS FOR THE TREATMENT OF THE ACUTE BACTERIAL SINUSITIS AND COMPLICATED URINARY TRACT INFECTION, CHRONIC BACTERIAL PROSTATITIS, ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS,COMMUNITY-ACQUIRED PNEUMONIA AND COMPLICATED SKIN AND SOFT TISSUE INFECTIONS. NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD ALLPHAMED PHARBIL ARZNEIMITTEL GMBH GERMANY CERTIFICATE RELEASED 09 I 5807/24 25-SEP-2024 24-SEP-2029 View
2740 LEVOFLOX-DENK 5 MG/ML LEVOFLOXACIN HEMIHYDRATE EQ.TO LEVOFLOXACIN 5 MG/ML SOLUTION FOR INFUSION VIAL COMMUNITY-ACQUIRED PNEUMONIA, COMPLICATED SKIN AND SOFT TISSUE INFECTION, PYELONEPHRITIS AND COMPLICATED URINARY TRACT INFECTION, CHRONIC BACTERIAL PROSTATITIS, INHALATION ANTHRAX:POST EXPOSURE PROPHYLAXIS AND CURATIVE TREATMENT NULL VIENGTHONG PHARMA IMPORT-EXPORT SOLE CO.,LTD SOLUPHARM PHARMACEUTISCHE ERZEUGNISSE GMBH GERMANY CERTIFICATE RELEASED 12 I 4853/19 14-SEP-2022 13-SEP-2025 View